Skip to main content
. 2021 Feb 10:1–6. doi: 10.1080/1354750X.2020.1861098

Figure 1.

Figure 1.

(A) The levels of ferritin in severe and non-severe patients on admission; (B) The variation of ferritin in severe and non-severe patients (days were calculated as the interval between the time point of symptom onset and ferritin examination); n = 11, 15 and 9 for days 1–10, 11–20 and 21–30 of severe group while n = 22, 36 and 16 for days 1–10, 11–20 and 21–30 of non-severe group); (C) The levels of ferritin in liver injury and normal liver patients on admission; (D) The variation of ferritin in liver injury and normal liver patients (days were calculated as the interval between the time point of symptom onset and ferritin examination; n = 13, 18 and 8 for days 1–10, 11–20 and 21–30 of liver injury group while n = 20, 33 and 20 for days 1–10, 11–20 and 21–30 of normal liver group); (E) CT manifestation of COVID-19 patients (the corresponding ferritin levels and time points are displayed on the top of each image). The data are shown as median (IQR); **p < 0.001; *p < 0.01. The classification of severity illness or liver injury were based on the symptoms or laboratory examinations on admission.